HYDERABAD, India, Oct 08, 2012 (BUSINESS WIRE) — The Custom Pharmaceutical Services (CPS) business of Dr. Reddy’s Laboratories Ltd. (NYSE:RDY) today announced expansion in the areas of activated mPEG manufacturing and in the development and …
Dr. Reddy’s Custom Pharmaceutical Services (CPS) Business Expands Its Manufacturing Operations in Mirfield, UK